Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) that require chiral cyclohexylamine derivatives. Its protected amine groups, specifically the tert-butyl carbamate (Boc) group, allow for selective reactions in multi-step organic syntheses, making it valuable in creating structurally complex drugs. The Boc group can be removed under acidic conditions to reveal the free amine. Commonly employed in the production of central nervous system agents and antiviral medications due to its stability and stereochemical properties. Also utilized in research settings for the preparation of novel amine-containing compounds where controlled deprotection is needed.